InvestorsHub Logo
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 918

Thursday, 08/06/2020 8:18:58 AM

Thursday, August 06, 2020 8:18:58 AM

Post# of 1162
BMY reports 2Q20 results—raises full-year EPS guidance slightly:

https://investors.bms.com/iframes/press-releases/press-release-details/2020/Bristol-Myers-Squibb-Reports-Second-Quarter-2020-Financial-Results/default.aspx

The new 2020 (non-GAAP) EPS guidance is $6.10-6.25 (up from the prior range of $6.00-6.20).

The biggest news, however, is the Eliquis patent win that was announced by the Court yesterday (#msg-157405334).

CC slides:
https://s21.q4cdn.com/104148044/files/doc_presentations/2020/BMY-Q22020-Earnings-Updates.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News